Chlorpromazine versus placebo for schizophrenia.

Author: AdamsClive E, AwadGeorge A, RathboneJohn, Soares-WeiserKarla, ThornleyBen

Paper Details 
Original Abstract of the Article :
BACKGROUND: Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia. OBJECTIVES: To review the effects of chlorpromazine compared with placebo, for the treatment of schizophrenia. SEARCH METHODS: We searched the Cochrane Schizophrenia Group's Trials Reg...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640712/

データ提供:米国国立医学図書館(NLM)

Chlorpromazine: A Well-Established Oasis in the Desert of Schizophrenia

The world of mental illness, my friends, is like a vast and often treacherous desert. This study is like a group of researchers revisiting a well-established oasis, chlorpromazine, a medication commonly used for schizophrenia. The researchers are conducting a comprehensive review of the available evidence, examining the effectiveness of chlorpromazine compared to a placebo in treating schizophrenia.

A Reliable Route for Schizophrenia Treatment: Revisiting Chlorpromazine's Effectiveness

The researchers discovered that chlorpromazine was effective in reducing relapse rates, improving overall symptom severity, and reducing the likelihood of patients dropping out of treatment. This review provides a strong foundation for understanding the benefits and risks of chlorpromazine as a treatment for schizophrenia.

Navigating the Desert of Schizophrenia: A Well-Established Oasis

As a camel, I've always valued the importance of reliable resources. This research is like a group of scientists re-evaluating a well-established oasis, chlorpromazine. The findings reaffirm the value of this medication as a treatment option for schizophrenia, highlighting its effectiveness in reducing relapse rates and improving overall outcomes.

Dr. Camel's Conclusion

This research is like a map guiding us through the desert of schizophrenia, reaffirming the effectiveness of chlorpromazine. The authors' comprehensive review provides valuable insights into the benefits and risks of this medication, offering a reliable resource for clinicians and patients alike. Chlorpromazine remains a valuable tool in the fight against this challenging condition.

Date :
  1. Date Completed 2014-07-01
  2. Date Revised 2023-11-13
Further Info :

Pubmed ID

24395698

DOI: Digital Object Identifier

PMC10640712

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.